Parametric two-stage sequential quality assurance test of dose content uniformity

Area of Science:

• Pharmaceutical Sciences
• Analytical Chemistry
• Quality Control

Background:

• The United States Pharmacopeia (USP) content uniformity sampling plan is a standard but often misused for lot quality assurance.
• Existing USP and harmonized European Pharmacopeia (EP)/USP methods exhibit limitations in discriminating between different lot quality profiles.
• These methods may be biased, particularly with off-target product means and variances.

Purpose of the Study:

• To propose a new parametric tolerance interval procedure for drug product content uniformity testing.
• To provide a statistically sound method equivalent to testing two one-sided hypotheses for two-sided specifications.
• To enhance the discrimination capability of content uniformity tests for lot quality assurance.

Main Methods:

• Development of a parametric tolerance interval procedure.
• Equivalence testing against the standard two one-sided hypotheses approach.
• Comparison of operating characteristic curves with the USP test procedure.

Main Results:

• The proposed procedure offers improved discrimination between lots with varying means and variances compared to the USP method.
• The USP procedure is less effective at distinguishing lots with on-target means/small variance from off-target means/large variance.
• The EP/USP harmonized test's 'no-difference zone' may introduce bias favoring off-target products.

Conclusions:

• The proposed parametric tolerance interval procedure provides a more accurate and less biased approach to content uniformity testing.
• This method better assures drug product efficacy (not under-dosed) and safety (not over-dosed).
• The findings highlight the need for improved statistical methods in pharmacopeial testing for robust quality assurance.